Drug Price Trends for NDC 83324-0091

Average Pharmacy Cost for 83324-0091

Drug Name	NDC	Price/Unit ($)	Unit	Date
QC ALLERGY (CETRZN) 10 MG TAB	83324-0091-14	0.06035	EACH	2024-12-18
QC ALLERGY (CETRZN) 10 MG TAB	83324-0091-14	0.06069	EACH	2024-12-11

Best Wholesale Price for NDC 83324-0091

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Drug Name	Vendor	NDC	Count	Price ($)	Price/Unit ($)	Dates	Price Type

83324-0091 Market Analysis and Financial Projection

Market Analysis and Price Projections for QC ALLERGY (Cetirizine) - NDC: 83324-0091

Global Allergy Market Overview

The global allergy market, which includes products like QC ALLERGY (cetirizine), is experiencing significant growth driven by increasing instances of allergic conditions. Here are some key points to consider:

• Market Growth: The global seasonal allergy market is projected to grow from US$ 1.22 billion in 2023 to US$ 2.58 billion by 2033, with a Compound Annual Growth Rate (CAGR) of 7.8% during the forecast period[5].
• Segmented Market: The seasonal allergic rhinitis market, another segment relevant to cetirizine, is expected to reach US$ 14.1 billion by 2034, growing at a CAGR of 2.76% from 2024 to 2034[5].

Cetirizine Market Specifics

Active Ingredient and Usage

• Cetirizine, the active ingredient in QC ALLERGY, is a widely used antihistamine for treating allergy symptoms such as sneezing, runny nose, and itchy eyes[5].

Market Size and Growth

• The global cetirizine hydrochloride market was valued at US$ 1,100 million in 2017 and is expected to grow at a CAGR of 3.2% from 2018 to 2026[5].

Regional Dominance

• North America: North America, particularly the United States, holds a dominant position in the cetirizine market due to the high prevalence of hay fever and allergic conjunctivitis. The region's large market share is attributed to the widespread use of antihistamines like cetirizine[5].
• Asia-Pacific: The Asia-Pacific region is expected to show significant growth in the allergy diagnostics and therapeutics market, including cetirizine, due to the large population and increasing incidence of allergies and asthma in countries like India and China[5].

Product Popularity

• Brand Recognition: Cetirizine-based products, such as ZYRTEC, are among the most commonly used treatments for allergic rhinitis. These products are popular due to their effectiveness in relieving symptoms[5].

Market Drivers

Increasing Incidence of Allergic Conditions

• The prevalence of allergic rhinitis and other allergic conditions is increasing globally, affecting around 10% to 30% of the population worldwide. This trend is expected to propel the demand for cetirizine and other antihistamines[5].

Advancements in Treatment Options

• Customized and targeted therapies, including biologics, are enhancing the treatment landscape for allergic conditions. This advancement is likely to increase the adoption of cetirizine and similar medications[5].

Consumer Trends

• There is a growing consumer trend towards holistic health methods and natural therapies, but conventional antihistamines like cetirizine remain a staple in allergy treatment due to their proven efficacy[5].

Price Projections and Market Dynamics

Pricing Trends

• The pricing of cetirizine products is influenced by factors such as production costs, regulatory environments, and market competition. Given the generic nature of cetirizine, prices are generally competitive and may fluctuate based on regional market dynamics[5].

Competitive Landscape

• The market for cetirizine is highly competitive, with major players like Johnson & Johnson (ZYRTEC), Bayer (Claritin), and other generic manufacturers. This competition helps keep prices in check while driving innovation in product formulations and delivery methods[5].

Specifics for NDC: 83324-0091

Product Details

• QC ALLERGY (CETRZN) 10 MG TAB: This product, with the NDC code 83324-0091, is a cetirizine hydrochloride tablet used for treating allergy symptoms. The price per unit has been tracked and reported, showing minor fluctuations over time[5].

Price Fluctuations

• As of December 2024, the price per unit for QC ALLERGY (CETRZN) 10 MG TAB was reported to be around $0.06035 per unit. This price can vary slightly based on the date and market conditions[5].

Regional Insights

North America

• North America, particularly the United States, is a significant market for cetirizine due to the high prevalence of allergic conditions. The U.S. market is expected to continue growing, driven by the demand for effective allergy treatments[5].

Asia-Pacific

• The Asia-Pacific region is expected to show significant growth in the allergy diagnostics and therapeutics market, including cetirizine, due to the large population and increasing incidence of allergies and asthma in countries like India and China[5].

Key Takeaways

• The global allergy market, including cetirizine products, is projected to grow significantly due to increasing allergic conditions.
• Cetirizine remains a popular and effective treatment for allergic rhinitis.
• The market is highly competitive, which helps maintain competitive pricing.
• Regional markets, especially North America and the Asia-Pacific, are crucial for the growth of cetirizine sales.

FAQs

1. What is the projected growth rate of the global seasonal allergy market?

   • The global seasonal allergy market is projected to grow at a CAGR of 7.8% from 2023 to 2033[5].

2. What is the expected market size of the seasonal allergic rhinitis market by 2034?

   • The seasonal allergic rhinitis market is expected to reach US$ 14.1 billion by 2034[5].

3. Why is the cetirizine market growing?

   • The cetirizine market is growing due to the increasing incidence of allergic conditions, advancements in treatment options, and consumer trends towards effective allergy treatments[5].

4. Which regions are dominant in the cetirizine market?

   • North America, particularly the United States, and the Asia-Pacific region are dominant in the cetirizine market[5].

5. How does competition affect the pricing of cetirizine products?

   • The competitive landscape, with major players like Johnson & Johnson and Bayer, helps keep prices competitive and drives innovation in product formulations and delivery methods[5].

Sources

1. Drug prices and trends for QC ALLERGY (CETRZN) - DrugPatentWatch[5]
2. Prescription Drug Price Transparency Results and Recommendations - Oregon Department of Consumer and Business Services[2]
3. Prescription Drug Price Transparency Results and Recommendations - Oregon Department of Consumer and Business Services[3]
4. National Drug Code Directory - FDA[4]